|
ZNF611 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.50580000000722E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.458700E-03 |
| Normal-vs-Stage2 |
4.469700E-02 |
| Normal-vs-Stage3 |
3.161000E-01 |
| Normal-vs-Stage4 |
7.288000E-01 |
| Stage1-vs-Stage2 |
6.811200E-01 |
| Stage1-vs-Stage3 |
7.640000E-01 |
| Stage1-vs-Stage4 |
1.713200E-01 |
| Stage2-vs-Stage3 |
6.050600E-01 |
| Stage2-vs-Stage4 |
1.076220E-01 |
| Stage3-vs-Stage4 |
4.238400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.035360E-04 |
| Normal-vs-AfricanAmerican |
6.203700E-02 |
| Normal-vs-Asian |
1.957020E-01 |
| Caucasian-vs-AfricanAmerican |
3.276600E-01 |
| Caucasian-vs-Asian |
1.644490E-02 |
| AfricanAmerican-vs-Asian |
2.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.416850E-04 |
| Normal-vs-Female |
7.838700E-03 |
| Male-vs-Female |
7.019600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.179190E-01 |
| Normal-vs-Extreme_Weight |
1.155040E-01 |
| Normal-vs-Obese |
1.384360E-03 |
| Normal-vs-Extreme_Obese |
4.828200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.023600E-01 |
| Normal_Weight-vs-Obese |
2.254200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.854600E-01 |
| Extreme_Weight-vs-Obese |
5.771600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.428000E-01 |
| Obese-vs-Extreme_Obese |
4.815400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.287200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.28589999999862E-05 |
| Normal-vs-Age(61-80Yrs) |
1.157640E-02 |
| Normal-vs-Age(81-100Yrs) |
8.106600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.115830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.060400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.853200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.380200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.331900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50496999999916E-05 |
| Normal-VS-Type2 PRCC |
7.131200E-01 |
| Normal-VS-KIRP CIMP |
6.755800E-01 |
| Normal-VS-Unclassified PRCC |
3.919500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.351600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.491200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.751800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.270000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.820300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.810400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.461000E-01 |
| Normal-vs-N1 |
3.061600E-01 |
| Normal-vs-N2 |
4.823200E-03 |
| N0-vs-N1 |
7.147200E-01 |
| N0-vs-N2 |
8.313700E-02 |
| N1-vs-N2 |
4.762400E-02 |
|
|
